Patients and Medical
Advancing health equity for the LGBTQIA+ community
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help.
More Articles
Commercial
Omnichannel: How will pharma get there?
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management
Patients and Medical
Advocacy in Hemophilia: Building the Future by Design
Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking
Commercial
Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble
Patients and Medical
Bringing hope in hemophilia
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment
Patients and Medical
Clinical trials: Japan’s next chapter
Post COVID-19, keeping patients at the center of plans for clinical trial design in Japan is vital
Multichannel
From the Great Resignation to the Great Re-Engagement
In the war for talent, an employee-centered focus on purpose, personal discovery, learning, and innovation is a winning strategy, says medical communications business Healthcare Consultancy Group (HCG)
Multichannel
How Pharma can win back its online voice
Is your content even a tiny part of the online conversations about your disease and therapeutic areas? A look at the search results might horrify you
Commercial
Paving the payment path for DTx
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed
Multichannel
Decode real-world data opportunities in rare disease
Better use of anonymised real-world data (RWD), and a willingness to collaborate broadly with regulators, payers and patients will be key to speeding new cures for rare disease